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LANGERHANS CELLS IN VITILIGO: A QUANTITATIVE STUDY*
JACK BROWN, M.D4t R. K. WINKLEMANN, M.D.t AND KLAUS WOLFF, M.D.tt
Vitiligo is a common disease of unknown
etiology characterized clinically by an ac-
quired and usually progressive loss of pig-
ment which can be histochemically demon-
strated by an absence or a marked reduction in
the number of 3, 4-dihydroxyphenylalanine
(dopa)-positive melanocytes. Although this re-
duction in the population of dopa-positive
melanocytes is widely appreciated, the role of
the Langerhans cell and its relationship to
the melanoeyte in this disease are not as yet
firmly established. Mieseher and Sehaaf (1),
using gold-impregnation techniques, reported
the presence of Langerhans cells in equal num-
bers in pigmented and nonpigmented epider-
mis of patients with vitiligo. Becker and
co-workers (2) reported that the number of Lan-
gerhans cells as well as the number of melano-
cytes of normal and vitiliginous skin was con-
stant. They concluded from their studies that
the Langerhans cell was identical to the melano-
eyte and that the variation in pigment in
the vitiliginous skin was due to a variation
in the physiologic function and not to the
number of melanoeytes.
Recent electron microscopic observations by
Birbeck and co-workers (3) indicate that
melanocytes are absent from vitiliginous skin
and are replaced in their basal-layer position
by cells indistinguishable from high-level clear
cells or Langerhans cells. These findings have
been interpreted to indicate that the Langer-
bans cell is a postdivisional product of the
melanoeyte and actually represents the inac-
tive melanocyte observed by other workers
with the light microscope.
All previous light microscopic studies of
the Langerhans cell in vitiligo have been criti-
cized because the unpredictable gold-im-
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pregnation or the supravital dye technique
has been used. The enzyme histoehemical
method for the demonstration of adenosine
triphosphatase (ATPase), however, has been
recently shown to permit a simple reproduci-
ble and probably specific demonstration (4—8)
of the Langerhans cell in several mammalian
species, and when applied to isolated epi-
dermal sheets (9) is an ideal method for
evaluating the Langerhans cell population
quantitatively. Because of the conflicting evi-
dence regarding the Langerhans cell-melanocyte
population in vitiligo, it was thought that a
reappraisal of this problem, utilizing this
method, was needed.
MATERIALs AND METHODs
Ten patients (eight women and two men) aged
30 to 66 years with typical vitiligo of long stand-
ing participated in this study. Following local anes-
thesia with 1% solution of xylocaine, 5-mm punch-
biopsy specimens were removed from the center
of untreated vitiliginous areas and from the closest
corresponding site of normal skia of the contra-
lateral side.
After removal of the subcutaneous tissue, pure
epidermal sheets were prepared from two portions
of each specimen by immersing them in 2 N so-
dium bromide solution for 4 hours. The epidermal
sheets were washed and fixed, as described else-
where (9), and one portion was incubated for the
demonstration of nucleoside triphosphatase using
adenosine triphosphate as substrate according to
the method of Waehstein and Meisel (10). The
other portion was incubated in dopa by the method
of Becker (11).
Vertical sections, cut on a cryostat at a thick-
ness of 15 p, were obtained from involved and un-
involved areas in eight patients. One half of each
section was incubated for the demonstration of
nucleoside triphosphatase and the other half was
incubated in dopa as described previously.
ATPase-positive dendritic cells were evaluated
in vertical sections in regard to their morphology
and intraepidermal distribution and compared with
the intraepidermal distribution of dopa-positive
melanocytes. Quantitative cell counts were made
on epidermal sheets by means of a reticle fitted
into the eyepiece of a microscope with an objec-
tive lens of X43. The size of the field outlined by
the reticle was calibrated, the cells in each of 10
randomly chosen fields were counted, and cell pop-
ulations were expressed as the mean number of
cells per square millimeter of epidermis.
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RESULTS
Individual figures obtained from tbe five re-
gions of the body examined are listed in Table
I. The number of Langerhans cells in normal-
appearing skin (Fig. 1 A and B) varied from
464 to 1,009/mm2 (mean 697). In involved
areas (Fig. 1 C and D), counts varied from
561 to 958 cells/mm2 (mean 731). Tests of
significance determined by analysis of vari-
ance of the square roots of tbe observed counts
disclosed no statistically significant difference
between the Langerhans cell population of in-
volved skin and that of uninvolved skin.
In the five samples obtained from the arm
the number of cells varied from 464 to 800/
mm2 in normal skin and from 537 to 860/mm2
in vitiliginous skin. Two samples were ob-
tained from the thigh and one each from the
axilla, wrist, and forearm. From these areas
the highest counts were obtained from the
forearm (1,009 and 958 cells/mm2 for unin-
volved and involved skin respectively), and
the lowest counts were observed from the
thigh (648 and 701 cells/mm2 respectively).
Examination of dopa-trcated epidermal
sheets revealed the absence of dopa-positive
mclanocytcs from the involved areas of six pa-
tients. In the remaining four patients, dopa-
positive mclanocytes were present but in
greatly reduced numbers. In uninvolved skin
they appeared to be present in normal num-
bers, varying from 732 to 1,715/mm2 (mean
1,315). Both the highest and the lowest count
were obtained from the arm, which was the
most frequently examined site. Although the
sample size is small, the distribution of dopa-
positive melanocytes is in close agreement with
the findings of Szabó (12) and of Staricco and
Pinkus (13).
The intraepidermal distribution of ATPase-
positive dendritic cells in vertical sections,
although similar in normal-appearing and
vitiliginous epidermis of individual patients,
varied considerably from patient to patient.
In most areas the majority of cells occupied a
suprabasilar position and were equally dis-
tributed throughout the stratum malpighii.
However, in some sections, particularly those
from thin epidermis such as the inner aspect
of the arm (Fig. 2 A and B) or the axilla,
ATPase-positive dendritic cells were located
predominantly in the basal layer.
TABLE I
Cell counts in involved and uninvolved
skin in vitiligo
Dopa-positive melanocytes were not ob-
served in any vertical sections of involved
skin, whereas in normal-appearing skin they
were confined to and almost entirely lined the
dermoepidermal junction.
DISCUSSION
The quantitative and morphologic Similar-
ities of the Langerhans cell population of in-
volved and uninvolved skin of vitiligo and
the lack of any numerical correlation between
the Langerhans cells and the dopa-positive
melanocytes indicate that the Langerhans cell
is not changed in this disease and support the
concept of Wolff and Winkelmann (8) that
these two cell lines are perhaps distinct and un-
related, contrary to the view proposed origi-
nally by Breathnaeh (14) and by Zelickson
(15) that Langerhans cells represent postdivi-
sional products of melanocytes.
The histochemical localization of ATPase
appears to be a unique property of Langcrhans
cells of man as well as several other mamma-
lian species. Electron microscopic studies of
guinea pig epidermis (7) have shown that
histochemically demonstrable ATPase is lim-
ited solely to this cell. Similar electron micro-
scopic studies in man have not been made,
but it appears likely that the Langerhans cell
of man also can be identified specifically with
Patient
1
2
3
4
5
6
7
8
9
10
Mean
Site
Arm
Arm
Arm
Arm
Arm
Forearm
Wrist
Axilla
Thigh
Thigh
Langerhans
cells,
no./mm
Norrnsl
skin skin
464 537
488 561
683 860
729 806
800 779
1,009 958
716 713
718 624
648 701
714 774
697 731
Dopa-positive
melanocytes,
no./mm5
Normal Vitilig-
skin
1,318 Absent
1,228 Absent
1,715 16
732 Absent
1,342 16
1,460 Absent
1,286 Absent
1,308 22
1,155 Absent
1,603 448
1,315 0—448
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FIG. 1. Epidermal sheets. Distribution and density of Langerhans cells in vitiligo. A and
B, Uninvolved skin. (ATPase; Xl15 and X365.) C and D, Involved skin. (ATPase; X115
and X365.)
this technique. Keratinocytes did not exhibit
this enzymatic reaction. ATPase-positive cells
did not contain melanin, and serial sections
treated by the dopa technique revealed ATPase
cells to be dopa-negative.
Our findings are in good agreement with
those of Ferreira-Marques (16), who studied
gold-impregnated vertical sections of normal
human epidermis and from an extrapolation of
vertical sections found 670 Langerhans
cells/mm2. Using the same method, Mieseher
and Schaaf (1) found typical gold-positive
dendritic cells in apparently equal numbers iii
involved and uninvolved skin of patients with
vitihgo.
Recently Riley (17) reported that the
ATPase-positivc dendritio cell population of
isolated epidermal sheets of normal-appearing
skin was equal to that of vitiliginous skin.
The counts of ATPase-positive cells (1,150 to
1,850/mm2) were higher than those in the pres-
ent study. We cannot account for the differ-
IF
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FIG. 2. Vertical sections demonstrating intraepidermal distribution of Langerhans cells in
thin epidermis of inner arm. (ATPase; X 100.) Note presence of several cells close to base-
ment membrane. A, Uninvolved skin. B, Involved skin.
ence in Langerhans cell counts in the two stud-
ies except by differences in technique. On
vertical section, Riley observed that the num-
ber of suprabasal ATPase-positive cells was
increased significantly in vitiliginous epi-
dermis, a finding we could not confirm.
Birbeck and co-workers (3) also thought
that gold-positive cells were increased in viti-
liginous areas in comparison with normal con-
trol material and that, in normal control skin,
these cells were seldom found close to or within
the basal cell layer. They encountered diffi-
culty in demonstrating gold-positive dendritic
cells in normal-appearing skin of patients
with vitiligo. Electron microscopic studies by
the same workers indicated that melanocytes
were absent, and cells indistinguishable from
Langerhans cells were found on the basement
membrane in number and position similar to
those of melanocytes of normal epidermis.
The variations in all of these studies of the
Langerhans cells in vitiligo may be the result
of differences in their intraepidermal dis-
tribution. Our observations indicate that this
distribution varies considerably and that, for
example, in regions with thick epidermis this
cell is located in a predominantly suprabasal
position, whereas in regions of thin epider-
mis, Langerhans cells frequently occupy a po-
sition close to or on the basement membrane in
both normal and vitiliginous skin.
Although the sample size in the present
study was small, considerable variation in the
Langerhans cell population was encountered
among the 10 patients and among the various
regions examined. For example, the popula-
tion in the arm varied from 464 to 860
cells/mm2 among the five patients studied.
This is in contrast to guinea pig epidermis
(9), in which the Langerhans cell population
appears to be highly constant from region to
region as well as from animal to animal. Our
knowledge of the regional distribution and
normal variation of the Langerhans cell popu-
lation in human epidermis must be in-
creased; but to date in a given individual,
Langerhans cell counts from some areas are
reasonably reproducible.
Our findings in dopa-incuhated material
agree with those of other workers (2, 3).
Dopa-positivc melanocytes were absent from
or greatly reduced in number in involved
skin and appeared to be present in normal
numbers in normal-appearing skin.
The concept that the Langerhans cell repre-
sents a distinct and separate cell line is sup-
ported by studies of guinea pig epidermis,
which show a highly constant Langerhans cell
population in contrast to the dopa-positive
melanocyte population, which varies greatly
in distribution (9). Recent studies of guinea
pig epidermis have also shown that the
Langerhans cell is not affected by melanogenic
stimuli such as ultraviolet light or carcino-
gens (18) but may be affected by other fac-
tors such as stripping off the stratum corneum
of guinea pig epidermis (19), in which event
the Langerhans cells, independently of pigment
cells, are almost entirely shed within 3 to 4
days after injury but repopulate the epidermis
'4
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in normal numbers in approximately 15 days.
It does not appear likely that stimulation of
the Langerhans cell population could produce
specific alterations in the melanocyte popu-
lation and consequently affect the process of
vitiligo.
5UMMAnY
Langerhans cells, demonstrated histoehemi-
eally by the method for adenosine triphos-
phatase, were studied in skin specimens from
involved and corresponding uninvolved areas
in 10 patients with vitiligo. Cell counts of
isolated epidermal sheets revealed regional and
individual variations but were similar for
the uninvolved and involved areas of the same
patient. The mean count of Langerhans cells
was 73 1/mm2 in involved areas and 697/mm2
in uninvolved areas. Studies of vertical sec-
tions showed variations in the intraepidermal
distribution of ATFase-positive dendritie cells,
which appeared to be related to epidermal
thickness.
The quantitative and morphologic similari-
ties of Langerhans cells in uninvolved and
involved skin from patients with vitiligo as
well as the lack of any numerical correlation
between Langerhans cell and melanoeyte pop-
ulations indicate that the Langerhans cell is
not an etiologie factor in this disease and that
these two cell lines are distinct and perhaps
unrelated.
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